AstraZeneca to onshore rare disease portfolio as part of its $50B pledge to the US

AstraZeneca will invest $2 billion to expand its presence in Maryland, its latest move to boost US manufacturing as part of a larger $50 billion pledge, the company announced Friday. The UK-based drugmaker will use ...